ROLE OF GABAPENTIN AS ADJUVANT ANALGESIC WITH OPIOIDS FOR NEUROPATHIC CANCER PAIN WHEN COMBINED WITH LOWDOSE AMITRIPTYLINE IN CANCER SUBJECTS OF TRIPURA, A NORTH EASTERN STATE OF INDIA
Journal Title: Journal of Evidence Based Medicine and Healthcare - Year 2015, Vol 2, Issue 36
Abstract
Neuropathic cancer pain is often refractory to standard opioid therapy. The use of adjuvant analgesics for neuropathic cancer pain is largely empirical. Although gabapentin is effective in the treatment of neuropathic cancer pain, some patients experience intolerable side effects sufficient to warrant discontinuation. This study aimed to compare the efficacy and safety of gabapentin when combined with low dose amitriptyline as adjuvant analgesic to opioid for neuropathic cancer pain. METHODS: It was a double blind placebo controlled Randomized Control Trial. 80 patients were randomized in four groups and intervention was given for 14 days. Primary and secondary outcome variables were assessed on day 8 and day 15 for statistical significance by ANOVA or chi square test as applicable. Group A: Gabapentin 100 mg b.d. + Amitriptyline 10 mg b.d.; Group B: Gabapentine 100 mg b.d. + placebo of Amitriptyline; Group C: Placebo of Gabapentine + Amitriptyline 10 mg b.d.; Group D: Placebo of Gabapentine + Placebo of Amitriptyline. RESULTS: 74 subjects completed the treatment. Worst pain score, Least Pain score, Average Pain score and current pain score in Numerical Rating Scale (NRS) by Brief Pain Inventory (BPI) in last 24 hour at enrolment, after 7 and 14 days of intervention has been measured as primary outcome variable and there were no significant difference of pain score in NRS between the groups. Among the secondary end point outcome variables only daily paroxysmal pain was significantly less (P = 0.02) in Gabapentin – amitriptyline + opioid group compared to only opioid group. CONCLUSION: Although gabapentin might be regarded as a promising new adjuvant analgesic for neuropathic cancer pain, our results indicated minimal clinical benefit. So controlled trial with higher dose of gabapentin is needed to establish its efficacy.
Authors and Affiliations
Debasis Ray, Partha Sarathi Sutradhar, Gautam Majumder, Amitava Ghosh
Keywords
Related Articles
- EP ID EP232933
- DOI 10.18410/jebmh/2015/781
- Views 55
- Downloads 0
RELATIONSHIP OF PROINFLAMMATORY CYTOKINES WITH MICROALBUMINURIA IN PATIENTS OF TYPE 2 DIABETES MELLITUS- IMPLICATIONS IN THE PATHOGENESIS OF DIABETIC NEPHROPATHY
BACKGROUND Type 2 diabetes mellitus is frequently associated with an increased inflammatory state. However, the relationship between of low grade inflammation and diabetic nephropathy still remains unclear with conflicti...
ASYMPTOMATIC CHRONIC CARRIER - A POTENTIAL HAZARD TO BLOOD RECIPIENTS - BLOOD BANK-BASED STUDY
BACKGROUND Blood transfusion is an effective mode of transmission of hepatitis C infection. Hepatitis C is an emerging infection in India, which was detected in 1989. US and Japan started screening for HCV in 1990, which...
TUBERCULOSIS AND HIV COINFECTION: A TERTIARY CARE HOSPITAL STUDY
OBJECTIVE The aim of the present study is to record the clinical, radiological profile of pulmonary and extra pulmonary tuberculosis (EPTB) in HIV positive patients. To win the battle against AIDS we have to fight agains...
A STUDY OF CARDIAC ARRHYTHMIAS IN YELLOW OLEANDER SEED POISONING- AN OBSERVATIONAL STUDY IN A TERTIARY CARE CENTRE
BACKGROUND Yellow oleander seed poisoning causes a wide variety of rhythm disturbances, electrocardiographic variations and abnormalities. some of them primarily due to cardio active glycosides and some are secondary to...
RETAINED PLACENTA AND ITS CLINICAL MANAGEMENT
102 cases of retained placenta admitted to Cheluvamba Hospital, Department of Obstetrics and Gynecology, Mysore Medical College between 1st January 1995 to 5th February 1997 were studied with a name to identify high risk...